ONT.L Stock Analysis
ON
Uncovered
Oxford Nanopore Technologies PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. The firm has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. Its segments include Life Science Research Tools (LSRT) and COVID-19 Testing. The LSRT segment offers products and services for research use. The COVID-19 Testing segment provides products for SAR Cov 2 testing. Its sequencing technology offers real-time analysis in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. The firm's products include MinION, GridION, PromethION 2 Solo, PromethION 24 and 48 devices, Flongle and VolTRAX, among others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five Flongle or MinION Flow Cells. PromethION 2 devices are for high-yield sequencing.